Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

56.32 +1.90 (+3.49%)
Streaming Delayed Price Updated: 9:52 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,456,905
Open 55.24
Bid (Size) 56.32 (100)
Ask (Size) 56.33 (200)
Prev. Close 54.42
Today's Range 55.23 - 56.49
52wk Range 42.52 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 4.40%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s... 
Via MarketMinute
Topics Economy Intellectual Property World Trade
News headline image
1 Top ETF I Plan to Load Up on in 2026 ↗
This ETF could produce robust total returns in 2026 and beyond. 
Via The Motley Fool
Topics ETFs Stocks

Performance

YTD
+5.3%
+5.3%
1 Month
+9.0%
+9.0%
3 Month
+26.1%
+26.1%
6 Month
+19.7%
+19.7%
1 Year
-0.6%
-0.6%

More News

Read More
News headline image
Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference
From Bristol Myers Squibb
Via Business Wire
News headline image
Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30
Via MarketMinute
Topics Intellectual Property
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky
Via StockStory
Topics Stocks
News headline image
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
2 Dividend Stocks to Scoop Up Without Hesitation Right Now ↗
Via The Motley Fool
Topics Bankruptcy Initial Public Offering
News headline image
Is Bristol Myers Squibb a Buy, Sell, or Hold in 2026? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
3 Drug Stocks to Buy at a Discount ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Bristol Myers Squibb Co (NYSE:BMY) Presents a Classic Value Investing Case Amid Transition ↗
Via Chartmill
Topics Intellectual Property
News headline image
Dividend Stocks Are the Gift that Will Keep On Giving You More Income in 2026 ↗
Via The Motley Fool
Topics Economy
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗
Via Stocktwits
Topics Government
News headline image
The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
Via MarketMinute
Topics Intellectual Property
News headline image
The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025
Via MarketMinute
Topics Economy
News headline image
Should Retirees Pull Their Money Out of the Stock Market in 2026? ↗
Via The Motley Fool
Topics ETFs Economy Retirement
News headline image
Bristol-Myers Squibb Co (NYSE:BMY) Offers a High-Quality Dividend Profile for Income Investors ↗
Via Chartmill
News headline image
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
From Bristol Myers Squibb
Via Business Wire
News headline image
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗
Via Stocktwits
Topics Government World Trade
News headline image
This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
These 2 Healthcare Stocks Just Declared Dividend Raises ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 56.32
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 01/07/26 09:52 AM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 125.15B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 125B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.